NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Modus Therapeutics secures $15.7m for sickle cell disease drug development Modus Therapeutics, a Swedish biotech firm specializing in sickle cell disease therapies, has successfully raised SEK 140 million… bypharmanewsdailyJuly 15, 2018